Literature DB >> 4821783

Parkinson disease treated with a suspected dopamine receptor agonist.

T N Chase, A C Woods, G A Glaubiger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4821783     DOI: 10.1001/archneur.1974.00490350041006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  5 in total

1.  Activity and acceptability of piribedil in Parkinson's disease: a multicentre study.

Authors:  P Rondot; M Ziegler
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

2.  Parkinsonism by haloperidol and piribedil.

Authors:  G U Corsini; M Del Zompo; A Spissu; A Mangoni; G L Gessa
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

Review 3.  Potential of transdermal drug delivery in Parkinson's disease.

Authors:  Ronald F Pfeiffer
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  Effects of apomorphine and piribedil on pentylenetetrazol-induced seizures in mice.

Authors:  W H Riffee; R E Wilcox; C P Goldman; R V Smith
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Dopamine Autoreceptor Regulation of a Hypothalamic Dopaminergic Network.

Authors:  Stefanos Stagkourakis; Hoseok Kim; David J Lyons; Christian Broberger
Journal:  Cell Rep       Date:  2016-04-14       Impact factor: 9.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.